Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis L Pisters

Showing results (81-90 of 162) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
The effects of a presurgical stress management intervention for men with prostate cancer undergoing radical prostatectomyPatricia A Parker, Curtis A Pettaway, Richard J Babaian, et al.
The Canadian Journal of Urology|October 28, 2014
Variant prostate carcinoma and elevated serum CA-125Mehmet Asim Bilen, Adriana Reyes, Deb Bhowmick, et al.
The Journal of Urology|October 9, 2003
Clinical features and treatment outcome of Hispanic men with prostate cancer following external beam radiotherapyCharles J Rosser, Deborah A Kuban, Lawrence B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinomaCharles J Rosser, Adriana O Reyes, Funda Vakar-Lopez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatmentVassiliki Tzelepi, Eleni Efstathiou, Sijin Wen, et al.
The Journal of Urology|September 6, 2006
Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experienceJames G Evans, Philippe E Spiess, Ashish M Kamat, et al.
BJU International|December 13, 2006
Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?Philippe E Spiess, Andrew K Lee, Joseph E Busby, et al.
BJU International|December 17, 2009
Management of urethral recurrence after orthotopic urinary diversionJennifer M Taylor, Philippe E Spiess, Wassim Kassouf, et al.
Urology|November 10, 2007
An in vivo orthotopic canine model to evaluate distribution of intraprostatic injectate: implications for gene therapy and drug delivery for prostate cancerWassim Kassouf, Gordon A Brown, Anil Shetty, et al.
BJU International|December 28, 2021
Lymphangioembolization for iatrogenic chylous ascites after retroperitoneal urological surgeryMary E Westerman, Steven M Yevich, Yoav Dori, et al.
Pageof 17

Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
The effects of a presurgical stress management intervention for men with prostate cancer undergoing radical prostatectomyPatricia A Parker, Curtis A Pettaway, Richard J Babaian, et al.
The Canadian Journal of Urology|October 28, 2014
Variant prostate carcinoma and elevated serum CA-125Mehmet Asim Bilen, Adriana Reyes, Deb Bhowmick, et al.
The Journal of Urology|October 9, 2003
Clinical features and treatment outcome of Hispanic men with prostate cancer following external beam radiotherapyCharles J Rosser, Deborah A Kuban, Lawrence B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinomaCharles J Rosser, Adriana O Reyes, Funda Vakar-Lopez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatmentVassiliki Tzelepi, Eleni Efstathiou, Sijin Wen, et al.
The Journal of Urology|September 6, 2006
Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experienceJames G Evans, Philippe E Spiess, Ashish M Kamat, et al.
BJU International|December 13, 2006
Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?Philippe E Spiess, Andrew K Lee, Joseph E Busby, et al.
BJU International|December 17, 2009
Management of urethral recurrence after orthotopic urinary diversionJennifer M Taylor, Philippe E Spiess, Wassim Kassouf, et al.
Urology|November 10, 2007
An in vivo orthotopic canine model to evaluate distribution of intraprostatic injectate: implications for gene therapy and drug delivery for prostate cancerWassim Kassouf, Gordon A Brown, Anil Shetty, et al.
BJU International|December 28, 2021
Lymphangioembolization for iatrogenic chylous ascites after retroperitoneal urological surgeryMary E Westerman, Steven M Yevich, Yoav Dori, et al.
Pageof 17